Skip to main content
. 2024 Jan 11;17(1):104. doi: 10.3390/ph17010104

Table 2.

Pharmacokinetic properties of compound 48.

Cpd No. Administration Cmax (ng/mL) t½ (h) CL (mL/h/kg) AUC 0–t
(nL/L·h)
F
48 i.v. (2 mg/kg) 587 ± 63.1 1.33 ± 0.11 82.7 ± 1.97 400 ± 9.29 n.a.
p.o. (10 mg/kg) 252 ± 22.0 1.20 ± 0.12 654 ± 125 31.8%